Search results
Results from the Health.Zone Content Network
of people receiving a COVID-19 vaccine for the first time experienced this side effect. Guillain-Barré syndrome (GBS). GBS is a rare side effect that can cause the immune system to attack healthy ...
The risk of developing tinnitus — a ringing in one or both ears — after COVID-19 vaccination appears to be low, and while some studies have identified a link between the two, more data is ...
Healthy adults have the option of receiving any of the three COVID-19 vaccines. These are the: Pfizer mRNA vaccine. Moderna mRNA vaccine. Johnson & Johnson (J&J) adenoviral vector vaccine ...
People aged 12 and above who got coronavirus vaccines before September 12, 2022: 1 dose of any of the 3 newer vaccines Children aged 5-11, regardless of previous vaccine status: 1 dose of Pfizer ...
COVID-19 vaccination mandates continue to change. Learn more about where the U.S. currently stands on requiring COVID-19 vaccines and tests. COVID-19: What to Do When Family Members Are Unvaccinated
The updated Novavax COVID-19 vaccine, for ages 12 years or older Johnson & Johnson's Janssen vaccine, a one-dose shot for people 18 years of age and older, was previously available; however it is ...
And through mass vaccination, COVID-19 rates have declined dramatically in the second quarter of 2021,” Amler told Healthline. More than 170 million doses of the COVID-19 vaccine have been ...
In February 2021, Novavax partnered with Takeda to manufacture the vaccine in Japan, where its COVID‑19 vaccine candidate is known as TAK-019. [54] Novavax signed an agreement with Serum Institute of India for mass scale production for developing and low-income countries. [55]